GlassScriptPhysician profile
Brittney Pugh
NPI 1679017230
$5,528.48
in general payments reported to CMS, 2019-2025
38 companies · $2,673 in 2025
The $2,673 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $334 · 2023: $1,151 · 2024: $1,371 · 2025: $2,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,095 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,094.82 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $828.38 | 2023-2025 | |
| Lilly USA, LLC | $514.92 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $483.42 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Corcept Therapeutics | $400.63 | 2025 | Korlym |
| Novo Nordisk INC | $373.71 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $293.49 | 2022-2025 | Veozah |
| Pfizer INC. | $279.69 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $264.25 | 2022-2025 | Farxiga, Airsupra |
| Axsome Therapeutics, INC. | $256.99 | 2025 | Auvelity |
| Abbott Laboratories | $249.42 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $248.85 | 2022-2025 | Evenity, Prolia, Otezla |
| Exact Sciences Corporation | $207.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $135.65 | 2024-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.44 | 2024-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $86.80 | 2022-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $79.77 | 2025 | Caplyta |
| Organon LLC | $76.38 | 2024-2025 | Nexplanon |
| Antares Pharma, INC. | $71.40 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $70.54 | 2022-2024 | Belsomra, Januvia, Steglatro |
| Noven Therapeutics, LLC | $49.18 | 2023 | Secuado |
| Grifols USA, LLC | $45.65 | 2024 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $35.54 | 2023-2025 | Spravato, Xarelto |
| Novartis Pharmaceuticals Corporation | $31.99 | 2025 | |
| Lundbeck LLC | $31.32 | 2024-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $28.90 | 2023-2025 | Gemtesa |
| Mylan Specialty L.P. | $28.33 | 2024 | Yupelri |
| Medtronic, INC. | $28.24 | 2023 | Intellis Adaptivestim |
| Optinose US, INC. | $23.86 | 2025 | |
| Halozyme INC | $23.62 | 2023 | |
| Sunovion Pharmaceuticals INC. | $19.47 | 2022 | |
| Dexcom, INC. | $19.20 | 2024 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $18.79 | 2023 | Quviviq |
| Exeltis, USA INC. | $17.74 | 2024 | Slynd |
| Sanofi-Aventis U.S. LLC | $16.25 | 2022 | |
| Renalytix Ai, INC. | $16.18 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Edwards Lifesciences Corporation | $13.77 | 2022 | |
| Currax Pharmaceuticals LLC | $13.54 | 2025 | Contrave |
| Biohaven Pharmaceutical Holding Company LTD. | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Pugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.